Testosterone for Hypogonadism Cleared So Far of Prostate Cancer Risk

(MedPage Today) -- Men treated with testosterone replacement therapy (TRT) for hypogonadism didn't have an increase in adverse prostate events, the TRAVERSE trial found. Over a mean follow-up of 33 months, those who used topical 1.62% testosterone...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news